Current partner codePEPTIDESDE

Industry sponsor intelligence

Antag TherapeuticsClinical Pipeline.

Lead-sponsor view of Antag Therapeutics's indexed peptide studies, development phases, active programs, completed work and recent registry changes.

Total
1
Recruiting
1
Active
0
Completed
0
Results posted
0
Avg enrollment
150

Pipeline overview

Programs by phase and activity.

Velocity

Antag Therapeutics trials by start year

Study start year · indexed snapshot

1110020262026: 1 trials

Development

Trials by phase

Early Phase 10
Phase 10
Phase 21
Phase 30
Phase 40
ProductStudiesEarly / IPhase IIPhase IIIPhase IVActive
Semaglutide101001

Active peptide trials

In motion now.

Completed trials

Finished registry records.

No studies in this snapshot.

Search sponsor records

All Antag Therapeutics studies.

This page groups studies where Antag Therapeutics is listed as the lead industry sponsor. Collaborator-only records are not included in the count.

1 matching study

End of 1 results